Alliance of translational medicine: On the way to get R&D, clinical affairs, biopharma & business

Abstract

The first Russia's Alliance of translational medicine (ATM) was created in December 2016 a Consortium agreement signed by the universities participating in the Russian academic excellence Program “5–100”: N. I. Lobachevsky Nizhny Novgorod state University, National Research Nuclear University “MEPhI”, National Research Tomsk State University, and the “Center for Strategic Research North-West” Foundation.The goal of the Alliance creation is to bring the Russian science into the global scientific and technological leadership in the breakthrough fronts of Biomedicine. Our strategy is to integrate biomedical technologies in the educational process, which would suit the practical solution to global problems, such as diagnostics and therapy of socially valuable diseases. Joint technology programs with industry will be rooting from the fields of medicine, industries and the research outcome will be commercialized.The ATM activity object is the translational, personalized and predictive medicine, which the participants defined as high-tech efficient performance and services to support development of therapeutics, support clinical decision based on specialized digital platforms, developing advanced and unique technologies of early diagnosis and treatment.Area of scientific specialization of the Alliance covers the key challenges of medicine – oncology, cardiology, neurodegenerative diseases. The group of participants and their partners will dramatically accelerate the rate of translation and reduce the overall expenses of getting scientific ideas into clinical and industrial practices that produce based on scientific evidence new individualized medicines, to develop novel approaches to secure predictive diagnostics and preventive manipulations. To do this, the Alliance members to integrate a database of research data and open each other access to a unique infrastructure.The strategic objective of the Alliance is the training of medical professionals: doctors, researchers, trained to work with high-tech equipment. We have developed a new portfolio of educational programs within the frame of three universities.The scientific potential of universities in the declared specialization – more than 20 internationally recognized research groups working in such emerging fields as nanotechnology, neuroscience, biosensing, imaging, computer modelling. The main feature of the Alliance is to focus on the industry to achieve outstanding results in translational medicine, we must concentrate the resources, money and time.Trust and co-operation in the scientific world will dominate.The Alliance of translational medicine is open to cooperation, to associate of the different types of partners: universities, hospitals, research centers and industrial companies.